|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 399.70 DKK | -2.20% |
|
-1.87% | -14.30% |
| 02-13 | Diary - Europe's STOXX 600 Corporate Earnings Week Ahead | RE |
| 02-09 | DNB Carnegie Lowers Price Target for Zealand Pharma to 595 Danish Kroner (610), Reiterates Buy | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 4.47B | |||||
| 51.48B | |||||
| 44.3B | |||||
| 31.72B | - | ||||
| 26.57B | - | ||||
| 21.17B |
- Stock Market
- Equities
- ZEAL Stock
- Charts Zealand Pharma A/S
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition